2022
DOI: 10.3389/fimmu.2022.951582
|View full text |Cite
|
Sign up to set email alerts
|

Integrative Analysis From Multicenter Studies Identifies a WGCNA-Derived Cancer-Associated Fibroblast Signature for Ovarian Cancer

Abstract: Cancer-associated fibroblasts (CAFs) are a major contributor to tumor stromal crosstalk in the tumor microenvironment (TME) and boost tumor progression by promoting angiogenesis and lymphangiogenesis. This study aimed to identify prognostic genes associated with CAFs that lead to high morbidity and mortality in ovarian cancer (OC) patients. We performed bioinformatics analysis in 16 multicenter studies (2,742 patients) and identified CAF-associated hub genes using the weighted gene co-expression network analys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
38
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 63 publications
(39 citation statements)
references
References 54 publications
1
38
0
Order By: Relevance
“…All statistical analyses in genome were performed using the R software (v.4.1.2). More detailed statistical methods are covered in the above section (22,23). The assessment of correlations between continuous variables was performed using Pearson's correlation coefficients.…”
Section: Discussionmentioning
confidence: 99%
“…All statistical analyses in genome were performed using the R software (v.4.1.2). More detailed statistical methods are covered in the above section (22,23). The assessment of correlations between continuous variables was performed using Pearson's correlation coefficients.…”
Section: Discussionmentioning
confidence: 99%
“…Sequences of targeting LEF1 from references as follows ( Xiao et al, 2021 ): shRNA1: GCG​ATT​TAG​CTG​ACA​TCA​A, shRNA2: AGA​TGT​CAA​CTC​CAA​ACA​A, shRNA3: GTT​GCT​GAG​TGT​ACT​CTA​A, shRNA-NC: TTC​TCC​GAA​CGT​GTC​ACG​T. Additional experimental details are presented in our previous study ( Feng et al, 2022a ; Feng et al, 2022b ; Cheng et al, 2022 ).…”
Section: Methodsmentioning
confidence: 99%
“…We excluded duplicate sequencing samples from the same patients and patients lacking complete follow-up information and with 0 survival days. We performed log2 [transcripts per million (TPM) + 1] transformation on the above raw data (14). Using the same exclusion criteria, 556 patients with COAD from the GEO database (GSE39582 cohort) were included as the validation cohort.…”
Section: Dataset and Preprocessingmentioning
confidence: 99%